Iterum Therapeutics (ITRM) News Today → Claim Your FREE 'AI Income Playbook' Now! (From The Oxford Club) (Ad) Free ITRM Stock Alerts $1.15 -0.02 (-1.71%) (As of 06/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31, 2024 | globenewswire.comIterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract InfectionsMay 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: IO Biotech (IOBT), Iterum Therapeutics (ITRM)May 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Iterum Therapeutics on Strong Market Potential and Financial StabilityMay 14, 2024 | insidermonkey.comIterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 Iterum Therapeutics PLC Earnings CallMay 13, 2024 | msn.comIterum Therapeutics Non-GAAP EPS of -$0.38 beats by $0.16May 13, 2024 | globenewswire.comIterum Therapeutics Reports First Quarter 2024 Financial ResultsMay 6, 2024 | globenewswire.comIterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024April 29, 2024 | finanznachrichten.deIterum Therapeutics PLC: Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral SulopenemApril 29, 2024 | msn.comIterum Therapeutics resubmits new drug application to U.S. FDA for oral sulopenemApril 29, 2024 | globenewswire.comIterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral SulopenemApril 2, 2024 | finance.yahoo.comIterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comIterum Therapeutics plc (ITRM) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Iterum Therapeutics PLC Earnings CallMarch 28, 2024 | finanznachrichten.deIterum Therapeutics PLC: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.comIterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | globenewswire.comIterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024March 15, 2024 | globenewswire.comIterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside ChatMarch 12, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening InnovationsMarch 6, 2024 | finance.yahoo.comIterum Therapeutics Provides Business UpdateFebruary 28, 2024 | investing.comIterum Therapeutics PLC (ITRM)February 24, 2024 | msn.comIterum Therapeutics (ITRM) Price Target Increased by 550.00% to 6.63February 1, 2024 | finance.yahoo.comSteven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLCFebruary 1, 2024 | msn.comIterum Shareholders Reject Board’s Share Issuance ProposalJanuary 31, 2024 | msn.comIterum Therapeutics Announces Triumph in Phase 3 uUTI TrialJanuary 30, 2024 | msn.comWhy Iterum Therapeutics Stock Is Trending TodayJanuary 30, 2024 | msn.comIterum meets main goal in late trial for uUTI treatment with oral sulopenemJanuary 30, 2024 | markets.businessinsider.comIterum Therapeutics's Late-stage REASSURE Trial Successfully Met Primary EndpointJanuary 30, 2024 | marketwatch.comIterum Therapeutics Says UTI Drug Trial Met Primary EndpointJanuary 30, 2024 | marketwatch.comIterum Therapeutics Shares Surge on Positive UTI Drug Trial ResultsJanuary 30, 2024 | finance.yahoo.comIterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract InfectionsJanuary 30, 2024 | marketbeat.comTrading was temporarily halted for "ITRM" at 06:01 AM with a stated reason of "News pending."December 28, 2023 | msn.comInsiders Buying Iterum Therapeutics And 3 Other Stocks Under $3November 29, 2023 | msn.comIterum Therapeutics director discloses purchase of 20K sharesNovember 15, 2023 | finance.yahoo.comIterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comQ3 2023 Iterum Therapeutics PLC Earnings CallNovember 14, 2023 | finanznachrichten.deIterum Therapeutics PLC: Iterum Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | msn.comIterum Therapeutics GAAP EPS of -$0.30November 14, 2023 | benzinga.comRecap: Iterum Therapeutics Q3 EarningsNovember 14, 2023 | finance.yahoo.comIterum Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 13, 2023 | msn.comIterum Therapeutics Q3 2023 Earnings PreviewNovember 13, 2023 | benzinga.comEarnings Outlook For Iterum TherapeuticsNovember 7, 2023 | finance.yahoo.comIterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023November 5, 2023 | morningstar.comIterum Therapeutics PLC ITRMOctober 24, 2023 | finance.yahoo.comIterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract InfectionsOctober 12, 2023 | finance.yahoo.comIterum Therapeutics to Present Data at IDWeek 2023August 12, 2023 | finance.yahoo.comQ2 2023 Iterum Therapeutics PLC Earnings CallAugust 11, 2023 | finanznachrichten.deIterum Therapeutics PLC: Iterum Therapeutics Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finance.yahoo.comIterum Therapeutics Reports Second Quarter 2023 Financial ResultsAugust 10, 2023 | benzinga.comIterum Therapeutics's Earnings: A Preview Get Iterum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Moonshot Coins for the Current Crypto Run (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. Just take a look: Claim your free seat by clicking here now. ITRM Media Mentions By Week ITRM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ITRM News Sentiment▼1.890.89▲Average Medical News Sentiment ITRM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ITRM Articles This Week▼11▲ITRM Articles Average Week Get Iterum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Milestone Pharmaceuticals News Annovis Bio News Vaccitech News Eledon Pharmaceuticals News Landos Biopharma News Cue Biopharma News Barinthus Biotherapeutics News Benitec Biopharma News Aileron Therapeutics News YS Biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ITRM) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored